NCT02581137 2026-04-13
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Arizona
Thomas Jefferson University
Dalarna County Council, Sweden
Skyline Biosciences
Instituto Nacional de Cancer, Brazil
University of Arkansas